@misc{indiciae1c231794cff5,
  title = {PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma},
  author = {Vidarsdottir, L. and Azimi, A. and Sigvaldadottir, I. and Rahmanto, A. S. and Petri, A. and Kauppinen, S. and Ingvar, C. and Jonsson, G. and Olsson, H. and Frostvik-Stolt, M. and Tuominen, R. and Sangfelt, O. and Pokrovskaja, K. and Hansson, J. and Grander, D. and Egyhazi-Brage, s. and Johnsson, P.},
  year = {2020},
  doi = {10.1101/2020.05.03.073627},
  url = {https://www.biorxiv.org/content/10.1101/2020.05.03.073627v1},
  note = {Source identifier: 10.1101/2020.05.03.073627}
}